116 related articles for article (PubMed ID: 26722434)
1. Contactin 1 as a potential biomarker promotes cell proliferation and invasion in thyroid cancer.
Shi K; Xu D; Yang C; Wang L; Pan W; Zheng C; Fan L
Int J Clin Exp Pathol; 2015; 8(10):12473-81. PubMed ID: 26722434
[TBL] [Abstract][Full Text] [Related]
2. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Contactin 1 promotes growth, migration and invasion in Hs578T breast cancer cells.
Chen N; He S; Geng J; Song ZJ; Han PH; Qin J; Zhao Z; Song YC; Wang HX; Dang CX
BMC Cell Biol; 2018 Apr; 19(1):5. PubMed ID: 29673312
[TBL] [Abstract][Full Text] [Related]
4. The gene encoding the mouse contactin-1 axonal glycoprotein is regulated by the collier/Olf1/EBF family early B-Cell factor 2 transcription factor.
Bizzoca A; Picocci S; Corsi P; Arbia S; Croci L; Consalez GG; Gennarini G
Dev Neurobiol; 2015 Dec; 75(12):1420-40. PubMed ID: 25820347
[TBL] [Abstract][Full Text] [Related]
5. Contactin 1: A potential therapeutic target and biomarker in gastric cancer.
Chen DH; Yu JW; Jiang BJ
World J Gastroenterol; 2015 Sep; 21(33):9707-16. PubMed ID: 26361417
[TBL] [Abstract][Full Text] [Related]
6. LMTK3 knockdown retards cell growth and invasion and promotes apoptosis in thyroid cancer.
Lu L; Yuan X; Zhang Q; Zhang H; Shen B
Mol Med Rep; 2017 Apr; 15(4):2015-2022. PubMed ID: 28260052
[TBL] [Abstract][Full Text] [Related]
7. Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling.
Mesa C; Mirza M; Mitsutake N; Sartor M; Medvedovic M; Tomlinson C; Knauf JA; Weber GF; Fagin JA
Cancer Res; 2006 Jul; 66(13):6521-9. PubMed ID: 16818623
[TBL] [Abstract][Full Text] [Related]
8. Upregulated CNTN1 is associated with lymph node metastasis and poor prognosis of colorectal cancer.
Li G; Zhang Z; Ge G; Fang K; Zhu J
Cancer Biomark; 2021; 30(2):193-201. PubMed ID: 33104020
[TBL] [Abstract][Full Text] [Related]
9. High iodine concentration attenuates RET/PTC3 oncogene activation in thyroid follicular cells.
Fiore AP; Fuziwara CS; Kimura ET
Thyroid; 2009 Nov; 19(11):1249-56. PubMed ID: 19725779
[TBL] [Abstract][Full Text] [Related]
10. Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas.
Rodrigues R; Roque L; Espadinha C; Pinto A; Domingues R; Dinis J; Catarino A; Pereira T; Leite V
Oncol Rep; 2007 Oct; 18(4):917-26. PubMed ID: 17786355
[TBL] [Abstract][Full Text] [Related]
11. Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer.
Yan J; Ojo D; Kapoor A; Lin X; Pinthus JH; Aziz T; Bismar TA; Wei F; Wong N; De Melo J; Cutz JC; Major P; Wood G; Peng H; Tang D
Cancer Res; 2016 Mar; 76(6):1603-14. PubMed ID: 26795349
[TBL] [Abstract][Full Text] [Related]
12. Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice.
Jin L; Burniat A; Dumont JE; Miot F; Corvilain B; Franc B
Br J Cancer; 2008 Dec; 99(11):1874-83. PubMed ID: 18985036
[TBL] [Abstract][Full Text] [Related]
13. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
Sawai H; Okada Y; Kazanjian K; Kim J; Hasan S; Hines OJ; Reber HA; Hoon DS; Eibl G
Cancer Res; 2005 Dec; 65(24):11536-44. PubMed ID: 16357163
[TBL] [Abstract][Full Text] [Related]
14. BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis.
Mitsutake N; Miyagishi M; Mitsutake S; Akeno N; Mesa C; Knauf JA; Zhang L; Taira K; Fagin JA
Endocrinology; 2006 Feb; 147(2):1014-9. PubMed ID: 16254036
[TBL] [Abstract][Full Text] [Related]
15. Contactin 1: An Important and Emerging Oncogenic Protein Promoting Cancer Progression and Metastasis.
Gu Y; Li T; Kapoor A; Major P; Tang D
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32752094
[TBL] [Abstract][Full Text] [Related]
16. [Frequency of RET/PTC rearrangement and somatic BRAF mutation in papillary thyroid cancer].
Rumiantsev PO; Zaletaev DV; Vasil'ev EV; Saenko VA; Il'in AA; Rumiantseva UV; Abrosimov AIu; Medvedev VS
Vopr Onkol; 2006; 52(2):145-9. PubMed ID: 17195637
[TBL] [Abstract][Full Text] [Related]
17. Identification of differentially expressed genes in papillary thyroid carcinomas with and without rearrangements of the tyrosine kinase receptors RET and/or NTRK1.
Musholt TJ; Brehm C; Hanack J; von Wasielewski R; Musholt PB
J Surg Res; 2006 Mar; 131(1):15-25. PubMed ID: 16256137
[TBL] [Abstract][Full Text] [Related]
18. Effects of silencing RET/PTC1 junction oncogene in human papillary thyroid carcinoma cells.
Gilbert-Sirieix M; Ripoche H; Malvy C; Massaad-Massade L
Thyroid; 2010 Oct; 20(10):1053-65. PubMed ID: 20615140
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway.
Fan Y; Guo Y
Int J Clin Exp Pathol; 2015; 8(9):10420-7. PubMed ID: 26617750
[TBL] [Abstract][Full Text] [Related]
20. Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions.
Ballester LY; Sarabia SF; Sayeed H; Patel N; Baalwa J; Athanassaki I; Hernandez JA; Fang E; Quintanilla NM; Roy A; López-Terrada DH
Pediatr Dev Pathol; 2016; 19(2):94-100. PubMed ID: 26366474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
